Brookfield Asset Management is one of the world's largest alternative asset managers, with more than $1 trillion in assets under management (AUM) across infrastructure, energy, private equity, real estate, and credit. For a manager of its scale, quarterly results are best judged not by headline net income, which swings with non-cash marks, but by recurring fee-related earnings, distributable earnings, and fee-bearing capital. These metrics reveal whether the firm is raising and deploying client capital that generates durable fee revenue. Coming after the July completion of the Oaktree acquisition and a record fundraising year, the third-quarter report offered investors a test of whether Brookfield's growth engine can sustain momentum even as its near-term outlook is recalibrated. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
For the third quarter of 2026, Brookfield Asset Management reported distributable earnings (DE) — a non-standard measure of cash earnings available to shareholders — of $763 million, or $0.47 per share, up 15% year over year. Fee-related earnings (FRE), which strip out carried interest and other volatile items to isolate recurring fee income, rose 15% to $864 million, or $0.54 per share. Both figures were in line with or modestly ahead of analyst expectations.
Total revenue reached $2.149 billion, up about 72% from the prior year, though much of that increase reflected $764 million of carried interest income versus $112 million a year earlier and the consolidation of Oaktree. Net income of roughly $3.0 billion was also elevated by a non-cash gain related to the Oaktree transaction, underscoring why management and analysts focus on FRE and DE rather than reported net income.
Fee-bearing capital climbed 13% to $682 billion, driven by $25 billion raised in the quarter and $123 billion raised year to date. The board declared a quarterly dividend of $0.5025 per share.
Investor attention centered on the recurring fee engine rather than the dramatic revenue and net income figures, which were distorted by carried interest and the Oaktree consolidation. Fee-related earnings growth of 15% and record fundraising were viewed positively, but the deceleration from the prior quarter's 20% FRE growth and a trimmed 2026 outlook tempered enthusiasm. Management now expects 2026 earnings to land "in line with" long-term targets, down from earlier guidance that had suggested results would exceed them. The stock has traded near its 52-week high following a strong run, leaving the market focused on whether record capital formation can translate into visible earnings acceleration into 2027. From what I see, this focus on recurring metrics provides a clearer picture than headline numbers.
Several catalysts will shape Brookfield Asset Management's trajectory in the quarters ahead. First is the timing of fee activation. The sixth vintage of its flagship core-plus global infrastructure strategy has secured about $26 billion in commitments and is tracking above its $30 billion target, but fees on the fund begin January 1, 2027, roughly two months later than previously planned. That timing shift is a key reason the 2026 outlook was adjusted.
Second is deployment. Brookfield reported $68 billion of uncalled, non-fee-earning commitments that could generate roughly $680 million of annual fees once deployed, making the pace of investment a direct driver of future fee growth.
Third is the AI infrastructure opportunity. Recent announcements — including a roughly $9 billion venture in Korea alongside NAVER and NVIDIA and a partnership with Drax in the United Kingdom — illustrate the scale of the pipeline, but these projects carry execution and capital-intensity considerations.
Finally, investors should watch margin trends and carried interest realization. FRE margin has compressed partly for presentational reasons tied to the Oaktree consolidation, while carried interest remains episodic. None of these factors change the firm's long-term growth framework, but they will determine the near-term earnings cadence. I'm watching this closely as the infrastructure pipeline develops.
In my own research workflow, I frequently rely on Tickeron’s AI Screener to quickly filter opportunities and compare performance metrics across asset managers. It helps surface ideas based on technical patterns, fundamentals, and AI-driven signals without spending hours on manual scans, which has been especially useful when evaluating firms like Brookfield amid shifting outlooks.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Moving Average Convergence Divergence (MACD) for BAM turned positive on October 05, 2026. Looking at past instances where BAM's MACD turned positive, the stock continued to rise in 33 of 45 cases over the following month. The odds of a continued upward trend are 73%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on BAM as a result. In 53 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 64%.
BAM moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for BAM crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.
Following a +3.96% 3-day Advance, the price is estimated to grow further. Considering data from situations where BAM advanced for three days, in 187 of 317 cases, the price rose further within the following month. The odds of a continued upward trend are 59%.
The Aroon Indicator entered an Uptrend today. In 129 of 242 cases where BAM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 53%.
The 10-day RSI Indicator for BAM moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 27 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 71%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 50-day moving average for BAM moved below the 200-day moving average on October 26, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BAM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
BAM broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is 29 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. BAM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 74 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BAM's P/B Ratio (11.153) is slightly higher than the industry average of (2.444). P/E Ratio (29.977) is within average values for comparable stocks, (-2.250). Projected Growth (PEG Ratio) (1.046) is also within normal values, averaging (1.319). Dividend Yield (0.038) settles around the average of (0.272) among similar stocks. P/S Ratio (15.198) is also within normal values, averaging (15.694).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BAM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry InvestmentManagers